We are live on ! Find out more
ANAB icon

AnaptysBio
ANAB

119 hedge funds and large institutions have $659M invested in AnaptysBio in 2023 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 31 increasing their positions, 44 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

23% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 13

21% more capital invested

Capital invested by funds: $545M → $659M (+$115M)

3% more funds holding

Funds holding: 116 → 119 (+3)

1.61% more ownership

Funds ownership: 114.2% → 115.81% (+1.6%)

7% more call options, than puts

Call options by funds: $1.28M | Put options by funds: $1.2M

30% less repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 44

Holders
119
Holders Change
+3
Holders Change %
+2.59%
% of All Funds
1.73%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.04%
New
16
Increased
31
Reduced
44
Closed
13
Calls
$1.28M
Puts
$1.2M
Net Calls
+$83K
Net Calls Change
+$146K

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$19.4M
2
DTC
Deep Track Capital
Connecticut
+$11.9M
3
FLAM
First Light Asset Management
Minnesota
+$7.7M
4
WP
Woodline Partners
California
+$6.11M
5
PAI
Palo Alto Investors
California
+$4.41M

Top Sellers

Rank Fund Capital Flow
1
B
Braidwell
Connecticut
-$18.9M
2
State Street
State Street
Massachusetts
-$8.43M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$5.57M
4
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$2.95M
5
SCM
Suvretta Capital Management
New York
-$2.15M
Name Holding Trade Value Shares
Change 		Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$4.44M +$120K +6,971 +3%
Fidelity Investments
27
Fidelity Investments
Massachusetts
$4.34M -$1.12M -64,904 -24%
D.E. Shaw & Co
28
D.E. Shaw & Co
New York
$3.43M +$249K +14,434 +10%
Charles Schwab
29
Charles Schwab
California
$3.1M +$31.2K +1,809 +1%
Goldman Sachs
30
Goldman Sachs
New York
$2.99M -$671K -38,900 -22%
OCA
31
Octagon Capital Advisors
New York
$2.57M +$2.07M +120,000 New
Citadel Advisors
32
Citadel Advisors
Florida
$2.46M -$1.23M -71,495 -38%
Two Sigma Advisers
33
Two Sigma Advisers
New York
$2.12M -$309K -17,900 -15%
Renaissance Technologies
34
Renaissance Technologies
New York
$2.05M +$50K +2,900 +3%
Hudson Bay Capital Management
35
Hudson Bay Capital Management
Connecticut
$2.03M -$86.2K -5,000 -5%
Macquarie Group
36
Macquarie Group
Australia
$2.01M – – –
Two Sigma Investments
37
Two Sigma Investments
New York
$1.87M -$346K -20,088 -19%
UOC
38
UBS O'Connor
Illinois
$1.87M -$644K -37,339 -30%
HF
39
HRT Financial
New York
$1.62M +$1.3M +75,633 New
Fisher Asset Management
40
Fisher Asset Management
Washington
$1.52M +$8.62K +500 +0.7%
Bank of New York Mellon
41
Bank of New York Mellon
New York
$1.5M +$10.9K +631 +0.9%
N
42
Nuveen
North Carolina
$1.14M -$336K -19,452 -27%
SC
43
Stempoint Capital
New York
$964K +$776K +45,000 New
Ensign Peak Advisors
44
Ensign Peak Advisors
Utah
$931K – – –
Victory Capital Management
45
Victory Capital Management
Texas
$924K -$9.49K -550 -1%
Susquehanna International Group
46
Susquehanna International Group
Pennsylvania
$798K +$79.9K +4,635 +14%
Federated Hermes
47
Federated Hermes
Pennsylvania
$772K – – –
Jacobs Levy Equity Management
48
Jacobs Levy Equity Management
New Jersey
$763K -$2.95M -171,160 -83%
FWM
49
FMB Wealth Management
California
$762K – – –
Marshall Wace
50
Marshall Wace
United Kingdom
$715K -$26.2K -1,520 -4%
1
2
3 4 5

ANAB Hedge Fund Activity: Q4 2023 in Review

119 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in AnaptysBio (ANAB) for Q4 2023, worth a combined $659M — up 21% from $545M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new ANAB positions and 13 closed out — a net gain of 3 holders — while 31 added to existing stakes and 44 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $19.4M. The largest seller was Braidwell, exiting entirely with an estimated $18.9M sold.

  • 119 institutional investors held AnaptysBio (ANAB) as of Q4 2023, up from 116 in Q3 2023.
  • Funds reported $659M of AnaptysBio stock for Q4 2023, up 21% quarter-over-quarter.
  • 16 funds opened new AnaptysBio positions in Q4 2023 and 13 closed out, a net change of +3 holders.
  • The largest AnaptysBio buyer in Q4 2023 was Morgan Stanley, an estimated $19.4M added.
  • The largest AnaptysBio seller in Q4 2023 was Braidwell, an estimated $18.9M sold.

Based on aggregated 13F filings for Q4 2023.